160 related articles for article (PubMed ID: 17336710)
1. Successful treatment of renal amyloidosis due to familial cold autoinflammatory syndrome using an interleukin 1 receptor antagonist.
Thornton BD; Hoffman HM; Bhat A; Don BR
Am J Kidney Dis; 2007 Mar; 49(3):477-81. PubMed ID: 17336710
[TBL] [Abstract][Full Text] [Related]
2. Anakinra prevents symptoms of familial cold autoinflammatory syndrome and Raynaud's disease.
Metyas SK; Hoffman HM
J Rheumatol; 2006 Oct; 33(10):2085-7. PubMed ID: 16981288
[TBL] [Abstract][Full Text] [Related]
3. Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist.
Hoffman HM; Rosengren S; Boyle DL; Cho JY; Nayar J; Mueller JL; Anderson JP; Wanderer AA; Firestein GS
Lancet; 2004 Nov 13-19; 364(9447):1779-85. PubMed ID: 15541451
[TBL] [Abstract][Full Text] [Related]
4. Familial cold autoinflammatory syndrome: phenotype and genotype of an autosomal dominant periodic fever.
Hoffman HM; Wanderer AA; Broide DH
J Allergy Clin Immunol; 2001 Oct; 108(4):615-20. PubMed ID: 11590390
[TBL] [Abstract][Full Text] [Related]
5. [Successful treatment of clinical manifestations of Muckle-Wells syndrome with anakinra].
Dybowski F; Jakobs B; Altmeyer P; Braun J
Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1863-6. PubMed ID: 16915547
[TBL] [Abstract][Full Text] [Related]
6. A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome.
Goldbach-Mansky R; Shroff SD; Wilson M; Snyder C; Plehn S; Barham B; Pham TH; Pucino F; Wesley RA; Papadopoulos JH; Weinstein SP; Mellis SJ; Kastner DL
Arthritis Rheum; 2008 Aug; 58(8):2432-42. PubMed ID: 18668591
[TBL] [Abstract][Full Text] [Related]
7. Familial cold auto-inflammatory syndrome (FCAS): characterization of symptomatology and impact on patients' lives.
Stych B; Dobrovolny D
Curr Med Res Opin; 2008 Jun; 24(6):1577-82. PubMed ID: 18423104
[TBL] [Abstract][Full Text] [Related]
8. Muckle-Wells syndrome: clinical and histological skin findings compatible with cold air urticaria in a large kindred.
Haas N; Küster W; Zuberbier T; Henz BM
Br J Dermatol; 2004 Jul; 151(1):99-104. PubMed ID: 15270877
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation.
Moser C; Pohl G; Haslinger I; Knapp S; Rowczenio D; Russel T; Lachmann HJ; Lang U; Kovarik J
Nephrol Dial Transplant; 2009 Feb; 24(2):676-8. PubMed ID: 19033248
[TBL] [Abstract][Full Text] [Related]
10. Response to IL-1-receptor antagonist in a child with familial cold autoinflammatory syndrome.
O'Connell SM; O'Regan GM; Bolger T; Hoffman HM; Cant A; Irvine AD; Watson RM
Pediatr Dermatol; 2007; 24(1):85-9. PubMed ID: 17300660
[TBL] [Abstract][Full Text] [Related]
11. New CIAS1 mutation and anakinra efficacy in overlapping of Muckle-Wells and familial cold autoinflammatory syndromes.
Maksimovic L; Stirnemann J; Caux F; Ravet N; Rouaghe S; Cuisset L; Letellier E; Grateau G; Morin AS; Fain O
Rheumatology (Oxford); 2008 Mar; 47(3):309-10. PubMed ID: 18174231
[TBL] [Abstract][Full Text] [Related]
12. Hearing improvement in a patient with variant Muckle-Wells syndrome in response to interleukin 1 receptor antagonism.
Rynne M; Maclean C; Bybee A; McDermott MF; Emery P
Ann Rheum Dis; 2006 Apr; 65(4):533-4. PubMed ID: 16531551
[TBL] [Abstract][Full Text] [Related]
13. Anti-interleukin 1 treatment in secondary amyloidosis associated with autoinflammatory diseases.
Topaloglu R; Batu ED; Orhan D; Ozen S; Besbas N
Pediatr Nephrol; 2016 Apr; 31(4):633-40. PubMed ID: 26563115
[TBL] [Abstract][Full Text] [Related]
14. Severe TNF receptor-associated periodic syndrome due to 2 TNFRSF1A mutations including a new F60V substitution.
Haas SL; Lohse P; Schmitt WH; Hildenbrand R; Karaorman M; Singer MV; Böcker U
Gastroenterology; 2006 Jan; 130(1):172-8. PubMed ID: 16401480
[TBL] [Abstract][Full Text] [Related]
15. Anakinra improves sensory deafness in a Japanese patient with Muckle-Wells syndrome, possibly by inhibiting the cryopyrin inflammasome.
Yamazaki T; Masumoto J; Agematsu K; Sawai N; Kobayashi S; Shigemura T; Yasui K; Koike K
Arthritis Rheum; 2008 Mar; 58(3):864-8. PubMed ID: 18311804
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1beta receptor antagonist (anakinra): an unrecognized autoinflammatory disease?
Picco P; Brisca G; Traverso F; Loy A; Gattorno M; Martini A
Arthritis Rheum; 2009 Jan; 60(1):264-8. PubMed ID: 19116906
[TBL] [Abstract][Full Text] [Related]
17. Favourable and sustained response to anakinra in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) with or without AA amyloidosis.
Obici L; Meini A; Cattalini M; Chicca S; Galliani M; Donadei S; Plebani A; Merlini G
Ann Rheum Dis; 2011 Aug; 70(8):1511-2. PubMed ID: 21173015
[No Abstract] [Full Text] [Related]
18. [Renal amyloidosis in a female with familial Mediterranean fever: clinical response to treatment with colchicine and infliximab].
Heras M; Sánchez R; Saiz A; Fernández-Reyes MJ; Molina A; Alvarez-Ude F
Nefrologia; 2009; 29(4):373-5. PubMed ID: 19668321
[No Abstract] [Full Text] [Related]
19. Recovery from deafness in a patient with Muckle-Wells syndrome treated with anakinra.
Mirault T; Launay D; Cuisset L; Hachulla E; Lambert M; Queyrel V; Quemeneur T; Morell-Dubois S; Hatron PY
Arthritis Rheum; 2006 May; 54(5):1697-700. PubMed ID: 16646042
[TBL] [Abstract][Full Text] [Related]
20. NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort.
Aróstegui JI; Arnal C; Merino R; Modesto C; Antonia Carballo M; Moreno P; García-Consuegra J; Naranjo A; Ramos E; de Paz P; Rius J; Plaza S; Yagüe J
Arthritis Rheum; 2007 Nov; 56(11):3805-13. PubMed ID: 17968944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
